An exploration of outcome criteria in nocturnal: Enuresis treatment. The way forward

Scandinavian Journal of Urology and Nephrology

Volumn 38, Issue 3, 2004, Pages 196-206

  Butler, Richard J ^a   Robinson, Joanne C ^a   Holland, Philip ^b   Doherty Williams, Dianne ^b  

^a East Leeds Primary Care Trust   (United Kingdom)

^b Leeds Acute Hospitals Trust   (United Kingdom)

Author keywords

Dryness scale; Nocturnal enuresis; Outcome criteria

Indexed keywords

CARBAMAZEPINE; DESMOPRESSIN; IMIPRAMINE; OXYBUTYNIN;

ACUPUNCTURE; BEHAVIOR THERAPY; COGNITIVE THERAPY; HUMAN; HYPNOSIS; MANIPULATIVE MEDICINE; MEDICAL LITERATURE; NOCTURNAL ENURESIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESEARCH; REVIEW; TREATMENT OUTCOME; ULTRASOUND THERAPY; WORLD HEALTH ORGANIZATION;

ENURESIS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; TERMINOLOGY;

EID: 1942533217     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310025470     Document Type: Review

References (117)

1. Van Gool JD, Nieuwenhuis E, ten Doeschate IOM, Messer TP, de Jong TPVM. Subtypes in monosymptomatic nocturnal enuresis. Scand J Urol Nephrol Suppl 1999; 202: 8-11.
2. Nijman R, Butler R, Van Gool J, Yeung CK, Barrer W, Hjalmas K. Conservative management of urinary incontinence in childhood. Incontinence. 2nd International Consultation In Continence 2002: 513-51.
3. Butler RJ. Establishment of working definitions in nocturnal enuresis. Arch Dis Child 1991; 66: 267-71.
4. Djurhuus JC, Norgaard JP, Hjalmas K. What is an acceptable treatment outcome? [Review]. Scand J Urol Nephrol Suppl 1997; 183: 75-7.
5. Houts AC, Berman JS, Abramson H. Effectiveness of psychological and pharmacological treatments for nocturnal enuresis. J Consult Clin Psychol 1994; 62: 737-45.
6. Morgan RTT Guidelines on minimum standards of practice in the treatment of enuresis. Bristol, UK: Enuresis Resource and Information Centre, 1996.
7. Hunt S. The concept of outcome. Scand J Urol Nephrol Suppl 1997; 183: 71-4.
8. Butler R, McGrigor V, Rogers J Bedwetting: treating the underlying problem. The three systems approach to management. London: Ferring, 2002.
9. Hjalmas K, Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila) 1993; Spec. No.: 19-24.
10. Hjalmas K. SWEET, the Swedish Enuresis Trial. Scand J Urol Nephrol Suppl 1995; 173: 89-92.
11. Hjalmas K, Hanson E, Hellstom AL, Kruse S, Sillen U. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial [SWEET] Group. Br J Urol 1998; 82: 704-9.
12. van Gool JD, Bloom DA, Butler RJ, Djurhuus JC, Hjalmas K, De Jong TPVM, et al. Conservative management in children. In: Abrams P, Khoury S, Wein A, editors. Incontinence. 1999: 489-550.
13. Eller DA, Homsy YL, Austin PF, Tanguay S, Cantor A. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. Scand J Urol Nephrol Suppl 1997; 183: 41-5.
14. Lottman H, Moutard ML. Treatment of nocturnal enuresis in France: an update. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 30.
15. Lackgren G, Lilja B, Neveus T, Stenberg A. Desmopressin in the treatment of severe nocturnal enuresis - a 7 year follow up study. Br J Urol 1998; 81: 17-23.
16. Vande Walle J, Vets E, Renson C, De Paepe H, Vanhoecke E, Vandaele J, et al. A rationalized use of the alarm system in children. BJU Int 2001; 87 (Suppl 1): 70.
17. Jensen IN, Kristensen G. Alarm treatment: analysis of response and relapse. Scand J Urol Nephrol Suppl 1999; 202: 73-5.
18. Jensen N, Kristensen G. Frequency of nightly wetting and the efficiency of alarm treatment of nocturnal enuresis. Scand J Urol Nephrol 2001; 35: 357-63.
19. Matthiesen TB, Rittig S, Djurhuus JC, Norgaard JP. A dose titration, and an open 6 week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 1994; 151: 460-3.
20. Key DW, Bloom DA, Sanvordenker J. Low-dose DDAVP in nocturnal enuresis. Clin Pediatr (Phila) 1992; 31: 299-301.
21. Kosar A, Akkus S, Savas S, Ozturk A, Serel TA, Kecelioglu M. Effect of ultrasound in the treatment of primary nocturnal enuresis. Scand J Urol Nephrol 2000; 34: 361-5.
22. Banerjee S, Srivastav A, Palan BM. Hypnosis and self-hypnosis in the management of nocturnal enuresis: a comparative study with imipramine therapy. Am J Clin Hypn 1993; 36: 113-9.
23. Neveus T, Lackgren G, Tuvemo T, Olsson U, Stenberg A. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations. J Urol 1999; 162: 2136-40.
24. Schulman SL, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 2001; 166: 2427-31.
25. Skoog SJ, Stokes A, Turner KL. Oral desmopressin: a randomised, double-blind, placebo-controlled study of effectiveness in children with primary nocturnal enuresis. J Urol 1997; 158: 1035-40.
26. Uygur MC, Ozgu IH, Ozen H, Ozen S, Toklu C, Ergen A, et al. Long-term treatment of nocturnal enuresis with desmopressin intranasal spray. Clin Pediatr (Phila) 1997; 36: 455-9.
27. Hunsballe JM, Hansen TK, Rittig S, Pedersen EB, Djurhuus JC. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis. Clin Endocrinol 1998; 49: 793-801.
28. Yannakoyorgos K, Loannides E, Zahariou A, Anagnostopoulos D, Kasselas V, Kalinderis A. Management of nocturnal enuresis in children with desmopressin and bladder physiotherapy. Pediatr Surg Int 1998; 13: 281-4.
29. Pretlow RA. Treatment of nocturnal enuresis with an ultra sound bladder volume controlled alarm device. J Urol 1999; 162: 1224-8.
30. Schulman SL, Colish Y, von Zuben FC, Kodman-Jones C. Effectiveness of treatments for nocturnal enuresis in a heterogenous population. Clin Pediatr (Phila) 2000; 39: 359-64.
31. Bradbury M. Combination therapy for nocturnal enuresis with desmopresin and an alarm device. Scand J Urol Nephrol Suppl 1997; 183: 61-3.
32. Bradbury MG, Meadow SR. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatr 1995; 84: 1014-8.
33. Hunsballe JM, Rittig S, Nborgaard JP, Pedersen EB, Djurhuus JC. Decreased vasopressin response in nocturnal enuresis during thirst stimulation. International Children's Continence Society Monogr Ser 1996; 1: 69-71.
34. Smellie JM, McGrigor VS, Meadow SR, Rose SJ, Douglas MF. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs. Arch Dis Child 1996; 75: 62-6.
35. Fly Hansen A, Jorgensen TM. Treatment of nocturnal enuresis with the bell and pad system. Scand J Urol Nephrol Suppl 1995; 173: 101-2.
36. Kaneko K, Fujinaga S, Ohtomo Y, Shimizu T, Yamashiro Y. Combined pharmacotherapy for nocturnal enuresis. Pediatr Nephrol 2001; 16: 662-4.
37. Said JA, Wilson PH, Hensley VR. Primary versus secondary enuresis: differential response to urine-alarm treatment. Child Family Behav Ther 1991; 13: 1-13.
38. Kahan E, Morel D, Amir J, Zelcer C. A controlled trial of desmopressin and behavioural therapy for nocturnal enuresis. Medicine (Baltimore) 1998; 77: 384-8.
39. Butler RJ. Monitoring influential factors in the achievement of bladder control: a case study. Clin Psychol Psychother 1994; 1: 111-5.
40. Gustafson R. Conditioning treatment of children's bedwetting: a follow-up and predictive study. Psychol Rep 1993; 72: 923-30.
41. Moffatt MEK, Cheang M. Predicting treatment outcome with conditioning alarms. Scand J Urol Nephrol Suppl 1995; 173: 119-22.
42. Boggs SR, Geffken GR, Johnson SB, Silverstein J. Behavioural treatment of nocturnal enuresis in children with insulin-dependent diabetes mellitus. J Pediatr Psychol 1992; 17: 111-8.
43. Butler RJ, Redfern EJ, Holland P. Children's notions about enuresis and the implications for treatment. Scand J Urol Nephrol Suppl 1994; 163: 39-47.
44. Oredsson AF, Jorgensen TM. Changes in nocturnal bladder capacity during treatment with the bell and pad for monosymptomatic nocturnal enuresis. J Urol 1998; 160: 166-9.
45. Akbal C, Tekgul S, Atsu N, Eskicorabci S, Bakkaloglu M, Kendi S. The preliminary results of intermittent oral desmopressin therapy in enuretic patients. BJU Int 2001; 87 (Suppl 1): 72.
46. Van Kampen M, Bogaret G, De Weerdt W, Feys H, De Raemaeker I, Baert L. Predictive factors of the efficacy of full spectrum therapy in the treatment of children and young adults with nocturnal enuresis. BJU Int 2001; 87 (Suppl 1): 13-77; 50.
47. Hansen AF, Jorgensen TM. Alarm treatment: influence on functional bladder capacity. Scand J Urol Nephrol Suppl 1997; 183: 59-60.
48. Watanabe H, Kawauchi A, Kitamori T, Azuma Y. Treatment systems for nocturnal enuresis according to an original classification system. Eur Urol 1994; 25: 43-50.
49. Tahmaz L, Kibar Y, Yildirim I, Ceylan S, Dayanc M. Combination therapy of imipramine with oxybutynin in children with enuresis nocturna. Urol Int 2000; 65: 135-9.
50. Hansen MN, Rittig S, Siggaard C, Kamperis K, Hvistendahl G, Schaumburg HL, et al. Intra-individual variability in nighttime urine production and functional bladder capacity estimated by home recordings in patients with nocturnal enuresis. J Urol 2001; 16: 2452-5.
51. Hvistendahl G, Rawashdeh Y, Hansen MN, Kamperis K, Rittig S, Djurhuus JC. Bladder capacities are not affected by DDAVP treatment. BJU Int 2001; 87 (Suppl 1): 69.
52. Bjorkstrom G, Hellstrom AL, Andersson S. Electro-acupuncture in the treatment of children with monosymptomatic nocturnal enuresis. Scand J Urol Nephrol 2000; 34: 21-6.
53. Schaumburg HL, Rittig S, Djurhuus JC. No relationship between family history of enuresis and response to desmopressin. J Urol 2001; 166: 2435-7.
54. Schaumburg HL, Rittig S, Djurhuus JC. Failure of family history to predict response to desmopressin in nocturnal enuresis. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 75.
55. Kruse S, Hellstrom AL, Hanson E, Hjalmas K, Sillen U The Swedish Enuresis Trial [SWEET] Group. Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: predictive factors. BJU Int 2001; 88: 572-6.
56. Leebeek-Groenewegen A, Blom J, Sukhai R, Van Der Heijden B. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. J Urol 2001; 166: 2456-8.
57. Hjalmas K. The Swedish Enuresis Trial [SWEET]: longterm use of desmopressin in primary monosymptomatic nocturnal enuresis. Preliminary result. International Children's Continence Society Monogr Ser 1996; 1: 83-86.
58. Heijden AJ, Sukhai RN, Leebeek-Groe-newe-gen AAM. Efficacy of combined desmopressin and alarm [DA] therapy on enuretic children. A double blind placebo controlled study. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 50.
59. Kamperis K, Rittig S, Siggaard C, Hansen M, Rawashdeh Y, Hvistendahl G, et al. Enuretics with normal bladder capacity. Differences between responders and non-responders. BJU Int 2001; 87 (Suppl 1): 51.
60. Rittig S, Schaumburg H, Schmidt F, Hunsballe JM, Hansen AF, Kirk J. Long term home studies of water balance in patients with nocturnal enuresis. Scand J Urol Nephrol Suppl 1997; 183: 25-7.
61. Yeung CK. Nocturnal enuresis in Hong Kong: different Chinese phenotypes. Scand J Urol Nephrol Suppl 1997: 183: 17-21.
62. Schulman S, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin acetate in children with primary nocturnal enuresis. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 51.
63. Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 1999; 162: 1049-54.
64. Vertucci P, Lanzi C, Capece G, Fano M, Gallai V, Margari L, et al. Desmopressin and imipramine in the management of nocturnal enuresis: a multicentre study. Br J Clin Pract 1997; 51: 27-31.
65. Terho P. Desmopressin in nocturnal enuresis. J Urol 1991; 145: 818-20.
66. Jankregt RA, Zweers HHM, Namdar Z. Evaluation of oral desmopressin in the management of primary nocturnal enuresis in adolescents and adults: a multicentre, randomised trial. International Children's Continence Society Monogr Ser 1996; 1: 87-90.
67. Honjo H, Kawauchi A, Naya Y, Ukimura O, Kojima M, Miki T, et al. Treatment of nocturnal enuresis by acupuncture. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 58.
68. Rushton HG, Belman AB, Zaontz MR, Skoog SJ, Sihelnik S. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol 1996; 156: 651-5.
69. Leboeuf C, Brown P, Herman A, Leembruggen K, Walton D, Crisp TC. Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther 1991; 14: 110-5.
70. Tullus K, Bergstrom R, Fosdal I, Winnergard I, Hjalmas K. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group. Acta Paediatr 1999; 88: 1274-8.
71. van Gool JD, Nieuwenhuis E, ten Doeschate IO, Messer TP, de Jong TP. Subtypes in monosymptomatic nocturnal enuresis. II. Scand J Urol Nephrol Suppl 1999; 202: 8-11.
72. Rushton HG, Belman AB, Skoog S, Zaontz MR, Sihelnik S. Predictors of response to desmopressin in children and adolescents with monosymptomatic nocturnal enuresis. Scand J Urol Nephrol Suppl 1995; 173: 109-11.
73. Medel R, Dieguez S, Herrera M, Arakelian G, Ayuso S, Canepa C, et al. 8AM values of plasmatic antidiuretic hormone [ADH] in monosymptomatic primary enuresis [MPE]. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 77.
74. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Arch Dis Child 1974; 49: 259-63.
75. Wagner W, Johnson SB, Walker D, Earther R, Wittner J. A controlled comparison of two treatments for nocturnal enuresis. J Pediatr 1982; 101: 302-7.
76. Norgaad JP, van Gool JD, Hjalmas K, Djurhuus JC, Hellstrom AL. Standardisation and definitions in lower urinary tract dysfunction in children. Br J Urol 1998; 81 (Suppl 3): 1-16.
77. Butler RJ Nocturnal enuresis: psychological perspectives. Bristol, UK: Wright/IOP Publishing Limited, 1987.
78. Wikstrom S, Tapper J. Are repeated desmopressin treatment attempts successful? Scand J Urol Nephrol Suppl 1997; 183: 33-4.
79. Robson LM. Enuresis treatment in the US. Scand J Urol Nephrol Suppl 1999; 202: 56-60.
80. Doleys DM, Ciminero AR, Tollison JW, Williams CL, Wells KC. Dry bed training and retention control training: a comparison. Behav Ther 1977; 8: 541-8.
81. Moffatt MEK, Harlos S, Kirshen AJ, Burd L. Desmopressin acetate and nocturnal enuresis: how much do we know? Pediatrics 1993; 92: 420-5.
82. Butler RJ, Holland P, Robinson J. Examination of the structured withdrawal program to prevent relapse of nocturnal enuresis. J Urol 2001; 166: 2463-6.
83. Neveus T. Oxybutynin, desmopressin and enuresis. J Urol 2001; 166: 2459-62.
84. Hamano S, Yamanishi T, Igarashi T, Ito H, Murakami S. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis. Eur Urol 2000; 37: 718-22.
85. Longstaffe S, Moffatt ME, Whalen JC. Behavioural and self-concept changes after six months of enuresis treatment: a randomised, controlled trial. Pediatrics 2000; 105: 935-40.
86. Butler RJ, Holland P, Redfern E. An examination of the structured withdrawal programme to prevent relapse with removal of medication. Final Programme Abstracts. 2nd Congress of the International Children's Continence Society, Denver, CO, 22-24 August, 1999: 54.
87. Neveus T, Stenberg A, Lackgren G, Tuvemo T, Hetta J. Sleep of children with enuresis: a polysomnographic study. Pediatrics 1999; 103: 1193-7.
88. Wood CM, Butler RJ, Penney MD, Holland PC. Pulsatile release of arginine vasopressin (AVP) and its effect on response to desmopressin in enuresis. Scand J Urol Nephrol Suppl 1994; 163: 93-101.
89. Devitt H, Holland P, Butler RJ, Redfern E, Hiley E, Roberts G. Plasma vasopressin and response to treatment in primary nocturnal enuresis. Arch Dis Child 1999; 80: 448-51.
90. Medel R, Dieguez S, Brindo M, Ayuso S, Canepa C, Ruarte A. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin. Br J Urol 1998; 81: 46-9.
91. Hogg RJ. Genetic factors as predictors for desmopressin treatment success. Scand J Urol Nephrol Suppl 1997; 183: 37-9.
92. Stenberg A, Lackgren G. Desmopressin tablet treatment in nocturnal enuresis. Scand J Urol Nephrol Suppl 1995; 173: 95-9.
93. Vertucci P, Lanzi C, Capece G, Fano M, Gallai V, Margari L, et al. Desmopressin and imipramine in the management of nocturnal enuresis: a multicentre study. Br J Clin Pract 1997; 51: 27-31.
94. Caione P, Giorgi PL, Passerini-Glazel G, Chiozza ML, Artibani W, Del Gado R, et al. Desmopressin [DDAVP] and oxybutynin in nocturnal enuresis: results of a multicentre trial. International Children's Continence Society Monogr Ser 1996; 1: 77-81.
95. Caione P, Arena F, Biraghi M, Cigna RM, Chendi RM, Chiozza ML. Nocturnal enuresis and daytime wetting: a multicentre trial with oxybutynin and desmopressin. Eur Urol 1997; 31: 459-63.
96. Hogg RJ, Husmann D. The role of family history in predicting response to desmopressin in nocturnal enuresis. J Urol 1993; 150: 444-5.
97. Vijverberg MAW, Elzinga-Plomp, Messer AP, van Gool JD, de Jong TPVM. Bladder rehabilitation, the effect of a cognitive training programme on urge incontinence. Eur Urol 1997; 31: 68-72.
98. Sternberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 1994; 94: 841-6.
99. Kosar A, Arikan N, Dincel C. Effectiveness of oxybutyninhydrochloride in the treatment of enuresis nocturna. Scand J Urol Nephrol 1999; 33: 115-8.
100. Eggert P, Chavez-Kattau K, Muller D. Age and weight related dosage of DDAVP in the treatment of primary nocturnal enuresis. BJU Int 2001; 87 (Suppl 1): 51.
101. Riccabona M, Oswald J, Glauninger P. Long term use and tapered dose reduction of intranasal desmopressin in the treatment of 155 enuretic children. Br J Urol 1998; 81 (Suppl 3): 24-5.
102. Evans JH, Meadow SR. Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response. Arch Dis Child 1992; 67: 184-8.
103. Serel TA, Perk H, Koyuncuoglu HR, Kosar A, Celik K, Deniz N. Acupuncture therapy in the management of persistent primary nocturnal enuresis. Scand J Urol Nephrol 2002; 35: 40-3.
104. Butler RJ, Holland P, Devitt H, Hiley E, Roberts G, Redfern E. The effectiveness of desmopressin in the treatment of childhood nocturnal enuresis: predicting response using pre-treatment variables. Br J Urol 1998; 81 (Suppl 3): 29-36.
105. Dittman RW, Wolter S. Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome? Eur Child Adolesc Psychiatry 1996; 5: 101-9.
106. Van Londen A, van Londen-Barentsen MWM, van Son MJ, Mulder GA. Arousal training for children suffering from nocturnal enuresis: a 21/2-year follow-up. Behav Res Ther 1993; 31: 613-5.
107. Chiozza ML, Plebani M, Scaccianoce C, Biraghi M, Zacchello G. Evaluation of antidiuretic hormone before and after long term treatment with desmopressin in a group of enuretic children. Br J Urol 1998; 81 (Suppl 3): 53-5.
108. Monda JM, Husmann A. Primary nocturnal enuresis: a comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems. J Urol 1995; 154: 745-8.
109. Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol 1999; 161: 90-2.
110. Iester A, Marchesi A, Cohen A, lester M, Bagnasco F, Bonelli R. Functional enuresis: pharmacological versus behavioural treatment. Childs Nerv Syst 1991; 7: 106-8.
111. Madersbacher H, Knoll M, Kliss G. Plasma AVP levels in children with nocturnal enuresis: predictive value and outcome 5 years later. International Children's Continence Society Monogr Ser 1996; 1: 73-5.
112. Al-Waili NS. Carbamazepine to treat primary nocturnal enuresis: double-blind study. Eur J Med Res 2000; 5: 40-1.
113. Snajderova M, Lehotska V, Kernova T, Kocnarova N, Archmanavoa E, Janda P, et al. Desmopressin in a long-term treatment of children with primary nocturnal enuresis - a symptomatic therapy? Eur J Paediatr 2001; 160: 197-8.
114. Kruse S, Hellstrom A-L, Hjalmas K. Daytime bladder dysfunction in therapy resistant nocturnal enuresis. Scand J Urol Nephrol 1999; 33: 49-52.
115. Muller D, Florkowski H, Chavez-Kattau K, Carlsson G, Eggert P. The effect of desmopressin on short term memory in children with primary nocturnal enuresis. J Urol 2001; 166: 2432-4.
116. Cendron M, Klauber G. Combination therapy in the treatment of persistent nocturnal enuresis. Br J Urol 1998; 81 (Suppl 3): 26-8.
117. Houts AC. Behavioural treatment for enuresis. Scand J Urol Nephrol Suppl 1995; 173: 83-7.